These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 17183189

  • 1. Peroxisome proliferator-activated receptor-gamma is expressed by rat peritoneal mesothelial cells: its potential role in peritoneal cavity local defense.
    Zhang YF, Yang X, Zhang YJ, Sun YL, Zou XL, Kong QY, Dong XQ, Ye XQ, Yu XQ.
    Am J Nephrol; 2006; 26(6):602-11. PubMed ID: 17183189
    [Abstract] [Full Text] [Related]

  • 2. Rosiglitazone, a Peroxisome Proliferator-Activated Receptor (PPAR)-γ Agonist, Attenuates Inflammation Via NF-κB Inhibition in Lipopolysaccharide-Induced Peritonitis.
    Zhang YF, Zou XL, Wu J, Yu XQ, Yang X.
    Inflammation; 2015 Dec; 38(6):2105-15. PubMed ID: 26047949
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of MIP-2 (CXCL2) expression by 15-deoxy-Delta(12,14)-prostaglandin J(2) in mouse peritoneal macrophages.
    Kim HY, Kim HS.
    Immunol Cell Biol; 2007 Jan; 85(1):60-7. PubMed ID: 17130903
    [Abstract] [Full Text] [Related]

  • 4. CD40 is expressed on rat peritoneal mesothelial cells and upregulates ICAM-1 production.
    Yang X, Ye R, Kong Q, Yang Q, Dong X, Yu X.
    Nephrol Dial Transplant; 2004 Jun; 19(6):1378-84. PubMed ID: 15069176
    [Abstract] [Full Text] [Related]

  • 5. Upregulation of LPS-induced chemokine KC expression by 15-deoxy-delta12,14-prostaglandin J2 in mouse peritoneal macrophages.
    Kim HY, Kim HK, Kim JR, Kim HS.
    Immunol Cell Biol; 2005 Jun; 83(3):286-93. PubMed ID: 15877607
    [Abstract] [Full Text] [Related]

  • 6. Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.
    Zingarelli B, Hake PW, Mangeshkar P, O'Connor M, Burroughs TJ, Piraino G, Denenberg A, Wong HR.
    Shock; 2007 Nov; 28(5):554-63. PubMed ID: 17589386
    [Abstract] [Full Text] [Related]

  • 7. Peroxisome proliferator-activated receptor gamma ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor gamma-dependent mechanisms.
    Polikandriotis JA, Mazzella LJ, Rupnow HL, Hart CM.
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1810-6. PubMed ID: 16020752
    [Abstract] [Full Text] [Related]

  • 8. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2.
    Bianchi A, Moulin D, Sebillaud S, Koufany M, Galteau MM, Netter P, Terlain B, Jouzeau JY.
    Arthritis Res Ther; 2005 Sep; 7(6):R1325-37. PubMed ID: 16277686
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 15-Deoxy-Delta12,14-prostaglandin J2 inhibits angiotensin II-induced fibronectin expression via hepatocyte growth factor induction in human peritoneal mesothelial cells.
    Yokoyama Y, Masaki T, Kiribayashi K, Nakashima A, Kokoroishi K, Ogawa T, Kohno N, Yorioka N.
    Ther Apher Dial; 2010 Feb; 14(1):43-51. PubMed ID: 20438519
    [Abstract] [Full Text] [Related]

  • 11. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
    Kaplan J, Cook JA, O'Connor M, Zingarelli B.
    Shock; 2007 Dec; 28(6):722-726. PubMed ID: 17621259
    [Abstract] [Full Text] [Related]

  • 12. 15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) signals through retinoic acid receptor-related orphan receptor-alpha but not peroxisome proliferator-activated receptor-gamma in human vascular endothelial cells: the effect of 15d-PGJ2 on tumor necrosis factor-alpha-induced gene expression.
    Migita H, Morser J.
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):710-6. PubMed ID: 15662020
    [Abstract] [Full Text] [Related]

  • 13. Effects of peroxisome proliferator-activated receptor gamma ligands ciglitazone and 15-deoxy-delta 12,14-prostaglandin J2 on rat cultured cerebellar granule neuronal viability.
    Smith SA, Monteith GR, Holman NA, Robinson JA, May FJ, Roberts-Thomson SJ.
    J Neurosci Res; 2003 Jun 15; 72(6):747-55. PubMed ID: 12774315
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Peroxisome proliferator-activated receptor gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells.
    Cheng J, Nakamura H, Imanishi H, Liu W, Morisaki T, Sugiyama T, Hada T.
    Biochem Biophys Res Commun; 2004 Sep 17; 322(2):458-64. PubMed ID: 15325252
    [Abstract] [Full Text] [Related]

  • 17. PPARγ ligand ciglitazone inhibits TNFα-induced ICAM-1 in human airway smooth muscle cells.
    Huang CD, Hsiung TC, Ho SC, Lee KY, Chan YF, Kuo LW, Lin SM, Wang CH, Lin HC, Kuo HP.
    Biomed J; 2014 Sep 17; 37(4):191-8. PubMed ID: 25116714
    [Abstract] [Full Text] [Related]

  • 18. The peroxisome proliferator-activated receptor gamma ligands, pioglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), have antineoplastic effects against hepatitis B virus-associated hepatocellular carcinoma cells.
    Shim J, Kim BH, Kim YI, Kim KY, Hwangbo Y, Jang JY, Dong SH, Kim HJ, Chang YW, Chang R.
    Int J Oncol; 2010 Jan 17; 36(1):223-31. PubMed ID: 19956851
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.